Choi Jinjung, Selmi Carlo, Leung Patrick S C, Kenny Thomas P, Roskams Tania, Gershwin M Eric
a Division of Rheumatology, Allergy and Clinical Immunology , University of California Davis , Davis , CA , USA.
b Division of Rheumatology , CHA University Medical Center , Bundang , Korea.
Expert Rev Clin Immunol. 2016 Jun;12(6):661-72. doi: 10.1586/1744666X.2016.1147956. Epub 2016 Feb 25.
Chemokines represent a major mediator of innate immunity and play a key role in the selective recruitment of cells during localized inflammatory responses. Beyond critical extracellular mediators of leukocyte trafficking, chemokines and their cognate receptors are expressed by a variety of resident and infiltrating cells (monocytes, lymphocytes, NK cells, mast cells, and NKT cells). Chemokines represent ideal candidates for mechanistic studies (particularly in murine models) to better understand the pathogenesis of chronic inflammation and possibly become biomarkers of disease. Nonetheless, therapeutic approaches targeting chemokines have led to unsatisfactory results in rheumatoid arthritis, while biologics against pro-inflammatory cytokines are being used worldwide with success. In this comprehensive review we will discuss the evidence supporting the involvement of chemokines and their specific receptors in mediating the effector cell response, utilizing the autoimmune/primary biliary cholangitis setting as a paradigm.
趋化因子是固有免疫的主要介质,在局部炎症反应期间细胞的选择性募集过程中发挥关键作用。除了作为白细胞迁移的关键细胞外介质,趋化因子及其同源受体由多种驻留细胞和浸润细胞(单核细胞、淋巴细胞、自然杀伤细胞、肥大细胞和自然杀伤T细胞)表达。趋化因子是机制研究(特别是在小鼠模型中)的理想候选者,有助于更好地理解慢性炎症的发病机制,并有可能成为疾病的生物标志物。尽管如此,针对趋化因子的治疗方法在类风湿性关节炎中取得的结果并不理想,而针对促炎细胞因子的生物制剂在全球范围内都得到了成功应用。在这篇全面综述中,我们将以自身免疫性/原发性胆汁性胆管炎为例,讨论支持趋化因子及其特异性受体参与介导效应细胞反应的证据。